Mounjaro, a innovative therapy from a pharmaceutical manufacturer, is sparking significant interest within the diabetes field . This subcutaneous medication works in a different way, targeting several pathways involved in blood sugar control : GIP and GLP-1. Early research suggest it may provide substantial benefits in blood sugar counts , conceiva